炎琥宁与利巴韦林联用治疗麻疹临床效果分析

Clinical Effect Analysis on Potassium Sodium Dehydroandroan Drographol and Ribavirin Combination Therapy of Measles

目的探讨针对麻疹患者,观察临床选择炎琥宁＋利巴韦林完成治疗后获得的临床效果。方法选择我院2013年1月~2015年1月麻疹患者110例。通过随机数表法完成麻疹患者的随机分组。C2组（对照组55例）：临床选择利巴韦林进行治疗。C1组（观察组55例）：临床选择炎琥宁＋利巴韦林进行治疗。对比两组麻疹患者在临床治愈率、患者退热时间以及皮疹消退时间等方面表现出的差异。结果两组麻疹患者分别完成临床治疗后,C1组患者疾病治愈率为81.82%,C2组为61.82%,C1组高于C2组麻疹患者（P〈0.05）结论针对麻疹患者,临床选择炎琥宁＋利巴韦林进行治疗,最终显著提高麻疹患者的生活质量。

Objective To study on patients with measles, observe clinical choice potassium sodium dehydroandroan drographol plus ribavirin completed clinical effect after treatment. Methods From January 2013 to January 2015, 110 cases of measles patients. Through the stochastic indicator method randomized complete measles patients. C2 group 55 cases（control group）： clinical choose ribavirin treatment. C1 group 55 patients（observation group）, clinical choose potassium sodium dehydroandroan drographol plus ribavirin treatment. Compared to two groups of patients with measles in patients with clinical cure rate, antifebrile time and show the difference of time fades, etc. Results Two groups of patients with measles were done after clinical treatment, C1 patients disease cure rate was 81.82%, the C2 group was 61.82%, C1 group is significantly higher than C2 measles patients（P〈0.05） Conclusion For patients with measles, clinical choice Potassium sodium dehydroandroan drographol plus ribavirin treatment, eventually improve the quality of life of patients with measles.